SCHEMBL2106323

SCHEMBL2106323

CCCCC(C)(C)[C](C)C

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FDPS P14324 6/20 0.36
TSHR P16473 3/20 0.33
LMNA P02545 3/20 0.33
ALDH1A1 P00352 2/20 0.33
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
THRB P10828 1/20 0.32
GGPS1 O95749 3/20 0.31
CES1 P23141 1/20 0.31
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
CYP4F2 P78329 1/20 0.30
CYP4A11 Q02928 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2108808 0.92 FDPS (0.39) FDPSTSHRTHRBGGPS1
SCHEMBL9754327 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL28277589 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL28344630 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL10759608 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL18305913 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL4869449 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL2108945 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL100346 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1
SCHEMBL28161118 0.89 GGPS1 (0.43) FDPSTSHRTHRBGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111479819-B Method for preparing peptide and method for treating alkali 中外制药株式会社 2024-06-14 CN disclosed
CN-117624307-A Process for preparing cyclic organic compounds 中外制药株式会社 2024-03-01 CN disclosed
CN-113164616-A Degradable hyaluronic acid hydrogel 阿森迪斯药物股份有限公司 2021-07-23 CN disclosed
US-10756269-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-08-25 US disclosed
CN-107251259-B Composition and light-emitting element using the same 住友化学株式会社 2020-06-30 CN disclosed
CN-110654127-A Method for producing film, method for producing organic EL element, and ink composition set for producing film 住友化学株式会社 2020-01-07 CN disclosed
CN-106893581-B Organic electroluminescent compounds, organic electroluminescence device and its application 南京高光半导体材料有限公司 2019-11-05 CN disclosed
CN-105017470-B Polymer compound and organic light-emitting display device with thin film encapsulation structure 三星显示有限公司 2019-09-27 CN disclosed
CN-105969543-B Flue dust cleaning agent after fire 江苏筑磊电子科技有限公司 2019-04-05 CN disclosed
CN-106892915-B Organic compound, organic electroluminescence device and its application 南京高光半导体材料有限公司 2019-02-22 CN disclosed
US-4880939-A ANTISECRETORY AGENTS, HYPOTENSIVES, ANTICOAGULANTS TORAY INDUSTRIES (JP) 1989-11-14 US disclosed
US-4801718-A HERBICIDES ELI LILLY AND COMPANY (US) 1989-01-31 US disclosed
US-4775692-A ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT TORAY INDUSTRIES, INC. (JP) 1988-10-04 US disclosed
EP-0274064-A2 2,5,6,7-Tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1988-07-13 EP disclosed
EP-0232776-A2 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1987-08-19 EP disclosed
US-4636243-A HERBICIDES ISOXAZOLES ELI LILLY AND COMPANY (US) 1987-01-13 US disclosed
US-4515625-A HERBICIDES ELI LILLY AND COMPANY (US) 1985-05-07 US disclosed
EP-0049071-B1 N-ARYLBENZAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1984-12-19 EP disclosed
US-4416683-A HERBICIDES ELI LILLY AND COMPANY (US) 1983-11-22 US disclosed
EP-0049071-A1 N-arylbenzamide derivatives ELI LILLY AND COMPANY (US) 1982-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10756269-B2 Composition and light emitting device using the same CRY1, AHR, ARNT FDPS 3861/4885TSHR 3510/4885LMNA 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.